ANTI ATHEROSCLEROTIC EFFECT OF ADIPONECTIN
Keywords:
adiponectin, atherosclerosis, cardiovascular, stroke.Abstract
Atherosclerosis is a chronic, inflammatory disease of the arterial wall. Atherosclerosis underlies many of the common causes of cardiovascular morbidity and mortality, including myocardial infarction (MI), peripheral vascular disease, and cerebrovascular. Cardiovascular disease (CVD) has become the most frequent cause of death globally and then stroke is the second leading cause of death worldwide and a major cause of long-term disability.Recent study shows that adiponectin exhibits potent antiatherosclerotic effects. Adiponectin is a protein secreted specifically from adipose tissue. Adiponectin has a potential inhibitory effect on all molecular mechanisms of atherosclerosis.
References
Douglas G. The Pathogenesis of Atherosclerosis. Pathogenesis, Risk Factors and Prevention. 2014; 480-484.
Libby P, dkk. Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans. Immunity. 2013; 38: 1092-1104.
Efstathiou SP dkk. Plasma Adiponectin Levels and Five-Year Survival After First-Ever Ischemic Stroke. Journal of American Heart Association. 2005; 36: 1915-1919.
Shils ME dkk. Modern Nutrition in Health and Disease: Dietotherapy, 6th Edition. Philadelphia: Lippincott Williams and Wilkin. 2006; 640-644.
Han SW, dkk. 2007. Adiponectin and Cardiovascular Disease. Journal of the American College of Cardiology. 2007; vol. 49, No. 5.
Kato H, Kashiwagi H, Shiraga M, dkk. Adiponectin Acts as an Endogenous Antithrombotic Factor. Arterioscler Thromb Vasc Biol. 2006; 26: 224-230.
Barseghian A. dkk. Adiponectin and Vulnerable Atherosclerotic Plaques. Journal of the American College of Cardiology. 2011; vol. 57, no. 7, 761-70.
Wang ZV dkk. Adiponectin, Cardiovascular Function and Hypertension. Journal of American Heart Association . 2008; 51: 8-14.
Meier U, Gressner AM. Endocrine Regulation of Energy Metabolism: Review of Pathobiochemical and Clinical Chemical Aspects of Leptin, Ghrelin, Adiponektin, and Resistin. Clinical Chemistry. 2004; 50 (9): 1511–1525.
Ouchi N, Kihara S, Arita Y. Novel Modulator for Endothelial Adhesion Molecules Adipocyte-Derived Plasma Protein Adiponectin. Circulation. 1999; 100: 24732476.
Okamoto Y, Kihara S, Funahashi T. Adiponectin: a key adipocytokine in metabolic syndrome. Clinical Science. 2006; 110: 267–278.
Ohashi K, Ouchi N, Kihara S dkk. Adiponectin I164T Mutation Is Associated With the Metabolic Syndrome and Coronary Artery Disease. Journal of the American College of Cardiology. 2004; 43: 7.
Matsumoto M, Ishikawa S and Kajii E. Association of Adiponectin With Cerebrovascular Disease: A Nested CaseControl Study. Journal of American Heart Association. 2008; 39: 323-328.
Nishimura M, Izumiya Y, Higuchi A. Adiponectin Prevents Cerebral Ischemic Injury Trough Endothelial Nitric Oxide Synthase Dependent Mechanisms. Circulation. 2008; 117: 216-223.
Ekmekci H, Ekmekci OB. The Role of Adiponectin in Atherosclerosis and Thrombosis. Clin Appl Thrombosis/Hemostasis. 2006; 12 (2): 163-168.
Spranger J, Verma S, Go¨ hring I, dkk. Adiponectin Does Not Cross the Blood-Brain Barrier but Modifies Cytokine Expression of Brain Endothelial Cells. Diabetes. 2006; 55: 141-147.
Goldstein BJ, Scalia R. Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function. The Journal of Clinical Endocrinology & Metabolism. 2004; 89 (6): 2563–2568.
Yatomi K, Miyamoto N, Kobayashi MK dkk. Pathophysiological Dual Action Of Adiponectin after Transient Focal Ischemia in Mouse Brain. Brain Research. 2009; 1297: 169-176.
Chen MP, Tsai JCR, Chung FM, Yang SS, dkk. Hypoadiponectinemia Is Associated With Ischemic Cerebrovascular Disease. Arterioscler Thromb Vasc Biol. 2005; 25: 821-826.
Ishizawa K, Dorjsuren N, Ishizawa YI. Inhibitory effects of adiponectin on plateletderived growth factor-induced mesangial cell migration. Journal of Endocrinology . 2009; 202: 309–316.
Motoshima H, Wu X, Sinha MK dkk. Differential Regulation of Adiponectin Secretion from Cultured Human Omental and Subcutaneous Adipocytes: Effects of Insulin and Rosiglitazone. The Journal of Clinical Endocrinology & Metabolism. 2002; 87 (12): 5662-5667.
